Figure 2

Most important factors encouraging the initiation of HCV treatment by subgroup. ** The treatment mentioned in subgroup descriptions refers to treatment with pegylated interferon and ribavirin (PR). **Difference between groups is statistically significant at p ≤ 0.05.Sample sizes may vary for individual factors because of missed questions or participant non-response.